Zhong Guo Xin Wen Wang·2025-10-09 11:10Core Insights - Hong Kong's government has successfully attracted 18 key enterprises, including three of the world's top ten pharmaceutical companies, marking a significant milestone with over 100 key enterprises now established in the region [1][3][4] - The new enterprises are expected to bring approximately HKD 60 billion in investments and create around 22,000 jobs, contributing positively to the local economy [3][4] Group 1: Pharmaceutical Companies - The three global pharmaceutical companies that have established operations in Hong Kong are Merck Group, Roche, and GlaxoSmithKline (GSK) [3][4] - GSK highlighted Hong Kong's geographical advantage within the Guangdong-Hong Kong-Macao Greater Bay Area, which positions it as an ideal base for connecting with mainland China [3] - Roche emphasized favorable market conditions provided by policies such as "Hong Kong-Macao Drug and Medical Device Pass," which supports their research and development efforts in both Hong Kong and Shenzhen [4] Group 2: Economic Impact - The introduction of these key enterprises is expected to inject significant economic momentum into Hong Kong, enhancing its innovation ecosystem and attracting further investment [3][4] - The new batch of enterprises includes leaders in artificial intelligence, autonomous driving technology, microelectronics, cross-border financial services, and influential new media platforms [3][4] - The fact that 40% of the new enterprises are from overseas reflects Hong Kong's ongoing appeal as an international metropolis and a hub for global innovation [4]